CalciMedica is trading at $1.22, up 6.09%, with no clear company-specific catalyst identified. - CalciMedica was already up 13.04% after-hours on October 22, also without a clear company-specific catalyst. - No specific October 23 announcement explaining the continued move was found; the CFO resignation was disclosed October 16 and was not attributed to disagreement with the company. - Major indices are lower in the supplied market context, so the gain does not appear to track that broad-market direction.